High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy
  with Cardiovascular Deep Learning
  Left ventricular hypertrophy (LVH) results from chronic remodeling caused by
a broad range of systemic and cardiovascular disease including hypertension,
aortic stenosis, hypertrophic cardiomyopathy, and cardiac amyloidosis. Early
detection and characterization of LVH can significantly impact patient care but
is limited by under-recognition of hypertrophy, measurement error and
variability, and difficulty differentiating etiologies of LVH. To overcome this
challenge, we present EchoNet-LVH - a deep learning workflow that automatically
quantifies ventricular hypertrophy with precision equal to human experts and
predicts etiology of LVH. Trained on 28,201 echocardiogram videos, our model
accurately measures intraventricular wall thickness (mean absolute error [MAE]
1.4mm, 95% CI 1.2-1.5mm), left ventricular diameter (MAE 2.4mm, 95% CI
2.2-2.6mm), and posterior wall thickness (MAE 1.2mm, 95% CI 1.1-1.3mm) and
classifies cardiac amyloidosis (area under the curve of 0.83) and hypertrophic
cardiomyopathy (AUC 0.98) from other etiologies of LVH. In external datasets
from independent domestic and international healthcare systems, EchoNet-LVH
accurately quantified ventricular parameters (R2 of 0.96 and 0.90 respectively)
and detected cardiac amyloidosis (AUC 0.79) and hypertrophic cardiomyopathy
(AUC 0.89) on the domestic external validation site. Leveraging measurements
across multiple heart beats, our model can more accurately identify subtle
changes in LV geometry and its causal etiologies. Compared to human experts,
EchoNet-LVH is fully automated, allowing for reproducible, precise
measurements, and lays the foundation for precision diagnosis of cardiac
hypertrophy. As a resource to promote further innovation, we also make publicly
available a large dataset of 23,212 annotated echocardiogram videos.
